1 Min Read
May 8 (Reuters) - AstraZeneca PLC:
* LYNPARZA TABLETS RECEIVE EU APPROVAL FOR TREATMENT OF PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.